A study protocol for a feasibility trial of telephone-delivered Adherence Therapy for adults with type 2 diabetes.
diabetes
feasibility study
nurses
nursing
protocol
telephone-delivered adherence therapy
Journal
Nursing open
ISSN: 2054-1058
Titre abrégé: Nurs Open
Pays: United States
ID NLM: 101675107
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
revised:
08
10
2020
received:
29
07
2020
accepted:
05
11
2020
pubmed:
21
1
2021
medline:
10
9
2021
entrez:
20
1
2021
Statut:
ppublish
Résumé
Adherence therapy is a candidate intervention to improve medication adherence and clinical outcomes in patients with type 2 diabetes. The feasibility of conducting a trial of adherence therapy in this population has not been established. The objective of this study is therefore to test the feasibility of conducting a randomized controlled trial of adherence therapy in a Middle Eastern context. A single-centre randomized controlled feasibility trial of adherence therapy in patients with type 2 diabetes. We will undertake an initial cultural adaptation of a telephone-delivered form of adherence therapy in four patients in a Middle Eastern context. Our subsequent feasibility trial will aim to recruit 40 non-adherent diabetic patients that will be randomly allocated to receive eight weekly 30-min telephone adherence therapy sessions delivered by a diabetes educator versus treatment as usual. Key outcomes of interest include the number of patients invited to take part in the trial that consent to participate and then go on to complete treatment. The findings of this study will determine the feasibility of undertaking a full randomized controlled trial of adherence therapy in patients with type 2 diabetes.
Identifiants
pubmed: 33471963
doi: 10.1002/nop2.735
pmc: PMC8046149
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1510-1519Informations de copyright
© 2020 The Authors. Nursing Open published by John Wiley & Sons Ltd.
Références
Patient Prefer Adherence. 2016 Jun 10;10:1051-62
pubmed: 27354775
Res Soc Work Pract. 2015 Jul 1;25(4):423-432
pubmed: 26213454
Diabet Med. 2015 Jun;32(6):725-37
pubmed: 25440507
Med Care. 2005 Jun;43(6):521-30
pubmed: 15908846
Int J Clin Pract. 2014 Aug;68(8):963-71
pubmed: 24750544
Trials. 2015 Jun 14;16:270
pubmed: 26072311
Br J Clin Pharmacol. 2020 Jul;86(7):1281-1288
pubmed: 31823381
BMC Med Res Methodol. 2010 Jul 16;10:67
pubmed: 20637084
Diabetes Res Clin Pract. 2017 Jun;128:40-50
pubmed: 28437734
Diabetes Care. 2004 Dec;27(12):2800-5
pubmed: 15562188
J Adv Nurs. 2019 Dec;75(12):3263-3271
pubmed: 31237000
Patient Prefer Adherence. 2016 Jul 22;10:1299-307
pubmed: 27524885
J Diabetes Sci Technol. 2008 May;2(3):509-17
pubmed: 19885219
BMC Psychiatry. 2016 Apr 06;16:90
pubmed: 27048373
Nurs Open. 2021 May;8(3):1510-1519
pubmed: 33471963
J Hum Hypertens. 2012 Feb;26(2):117-26
pubmed: 21326328
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003638
pubmed: 15846672
Br J Psychiatry. 2004 Aug;185:157-62
pubmed: 15286068
Br J Psychiatry. 2006 Dec;189:508-14
pubmed: 17139034
Am J Prev Med. 2009 Feb;36(2):165-73
pubmed: 19135907
Int J Clin Pharm. 2011 Oct;33(5):779-87
pubmed: 21735249
Diabet Med. 2013 May;30(5):512-24
pubmed: 23323988
Ann Pharmacother. 2014 May;48(5):562-70
pubmed: 24586059
Clin Nurs Res. 2015 Oct;24(5):539-55
pubmed: 25106809
Diabet Med. 2011 Apr;28(4):455-63
pubmed: 21392066
Saudi Med J. 2016 Feb;37(2):121-6
pubmed: 26837392
Cochrane Database Syst Rev. 2014 Nov 20;(11):CD000011
pubmed: 25412402
Diabetes Educ. 2012 May-Jun;38(3):397-408
pubmed: 22446035
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Schizophr Res. 2013 May;146(1-3):59-63
pubmed: 23452506
J Psychosom Res. 2014 Feb;76(2):134-8
pubmed: 24439689
PLoS One. 2017 Feb 13;12(2):e0171863
pubmed: 28192467
Diabetes Manag (Lond). 2014 Jan 1;4(1):29-48
pubmed: 25214893
J Clin Nurs. 2013 Jul;22(13-14):2039-52
pubmed: 23441835